| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038469060 |
| P356 | DOI | 10.1038/SJ.GT.3301079 |
| P698 | PubMed publication ID | 10694800 |
| P5875 | ResearchGate publication ID | 12620432 |
| P50 | author | Hugo A. Katus | Q27929168 |
| P2093 | author name string | Steinbeck G | |
| Baretton G | |||
| Boekstegers P | |||
| Franz WM | |||
| Middeler G | |||
| Hullin R | |||
| Heinrich D | |||
| Kupatt C | |||
| Giehrl W | |||
| von Degenfeld G | |||
| P2860 | cites work | A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding | Q25938984 |
| A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal | Q35915922 | ||
| Ultrarapid, highly efficient viral gene transfer to the heart | Q36144261 | ||
| A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase | Q37551841 | ||
| Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice | Q38566634 | ||
| Analysis of tissue-specific gene delivery by recombinant adenoviruses containing cardiac-specific promoters | Q40871756 | ||
| Optimal techniques for arterial gene transfer. | Q40871768 | ||
| Cardiovascular gene therapy: current concepts | Q41152086 | ||
| Gene therapy for collateral vessel development. | Q41671835 | ||
| Efficient in vivo catheter-based pericardial gene transfer mediated by adenoviral vectors. | Q45855882 | ||
| Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors | Q45866323 | ||
| Percutaneous transluminal in vivo gene transfer by recombinant adenovirus in normal porcine coronary arteries, atherosclerotic arteries, and two models of coronary restenosis | Q45871121 | ||
| Physiological effects of adenoviral gene transfer of sarcoplasmic reticulum calcium ATPase in isolated rat myocytes | Q45880430 | ||
| beta-Galactosidase staining following intracoronary infusion of cationic liposomes in the in vivo rabbit heart is produced by microinfarction rather than effective gene transfer: a cautionary tale | Q45887497 | ||
| Acceleration of widespread adenoviral gene transfer to intact rabbit hearts by coronary perfusion with low calcium and serotonin | Q45889788 | ||
| Pharmacokinetic analysis of coronary venous retroinfusion: A comparison with anterograde coronary artery drug administration using metoprolol as a tracer | Q46033435 | ||
| Adenovirus-mediated gene transfer reconstitutes depressed sarcoplasmic reticulum Ca2+-ATPase levels and shortens prolonged cardiac myocyte Ca2+ transients | Q46403468 | ||
| Effect of the organic Ca2+ channel blocker D-600 on sarcoplasmic reticulum Ca2+ uptake in skeletal muscle. | Q53977306 | ||
| Pharmacokinetic analysis of coronary sinus retroinfusion in pigs. Ischemic myocardial concentrations in the left circumflex coronary arterial area using metoprolol as a tracer. | Q54071953 | ||
| Efficient gene transfer into myocardium by direct injection of adenovirus vectors | Q64377591 | ||
| Expression from cardiomyocyte-specific promoter after adenovirus-mediated gene transfer in vitro and in vivo | Q64382496 | ||
| Arterial gene transfer to rabbit endothelial and smooth muscle cells using percutaneous delivery of an adenoviral vector | Q64383432 | ||
| Occult ascending aortic rupture in the presence of an air bag | Q71226230 | ||
| The protective effect of L-arginine on myocardial injury and endothelial function following ischaemia and reperfusion in the pig | Q72113713 | ||
| Preservation of regional myocardial function and myocardial oxygen tension during acute ischemia in pigs: comparison of selective synchronized suction and retroinfusion of coronary veins to synchronized coronary venous retroperfusion | Q72740851 | ||
| Comparison of Pura-Vario and Palmaz-Schatz stents following implantation using normal and high pressure in pigs: immediate and late results assessed by 3-dimensional IVUS | Q73373224 | ||
| Targeting of dobutamine to ischemic myocardium without systemic effects by selective suction and pressure-regulated retroinfusion | Q73828899 | ||
| Selective suction and pressure-regulated retroinfusion: an effective and safe approach to retrograde protection against myocardial ischemia in patients undergoing normal and high risk percutaneous transluminal coronary angioplasty | Q74648345 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 232-240 | |
| P577 | publication date | 2000-02-01 | |
| P1433 | published in | Gene Therapy | Q15763095 |
| P1476 | title | Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins | |
| P478 | volume | 7 |
| Q44737488 | A minimally invasive approach for efficient gene delivery to rodent hearts |
| Q34669335 | A needleless liquid jet injection delivery method for cardiac gene therapy: a comparative evaluation versus standard routes of delivery reveals enhanced therapeutic retention and cardiac specific gene expression |
| Q36185039 | A pharmacokinetic analysis of molecular cardiac surgery with recirculation mediated delivery of βARKct gene therapy: developing a quantitative definition of the therapeutic window |
| Q37982681 | Adjuvant early and late cardioprotective therapy: access to the heart. |
| Q37766138 | Advances in gene-based therapy for heart failure |
| Q38637597 | Angiogenic gene therapy for refractory angina |
| Q34981655 | Biointerventional cardiology: the future interface of interventional cardiovascular medicine and bioengineering |
| Q45862445 | Cardiac Gene Delivery in Large Animal Models: Antegrade Techniques |
| Q34409721 | Cardiac Gene Therapy |
| Q37811189 | Cardiac gene therapy with SERCA2a: From bench to bedside |
| Q39124456 | Cardiac gene therapy with adeno-associated virus-based vectors. |
| Q38820937 | Cardiac gene therapy: are we there yet? |
| Q37965045 | Cardiac gene therapy: from concept to reality |
| Q33832137 | Cardiac gene therapy: optimization of gene delivery techniques in vivo |
| Q45872017 | Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors |
| Q34191737 | Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade |
| Q38788217 | Current Methods in Cardiac Gene Therapy: Overview |
| Q36931967 | Current strategies for myocardial gene delivery |
| Q35050717 | Defining the success of cardiac gene therapy: how can nuclear imaging contribute? |
| Q36690614 | Endometrial regenerative cells for treatment of heart failure: a new stem cell enters the clinic |
| Q37939775 | Gene delivery methods in cardiac gene therapy |
| Q36617570 | Gene targeting in ischemic heart disease and failure: translational and clinical studies |
| Q30427066 | Gene therapy delivery systems for enhancing viral and nonviral vectors for cardiac diseases: current concepts and future applications |
| Q42156793 | Gene therapy during cardiac surgery: role of surgical technique to minimize collateral organ gene expression |
| Q36800517 | Gene therapy for cardiac arrhythmias: a dream soon to come true? |
| Q38132253 | Gene therapy for heart disease: molecular targets, vectors and modes of delivery to myocardium |
| Q83556143 | Gene therapy for heart failure |
| Q38073152 | Gene therapy for heart failure: where do we stand? |
| Q37857290 | Gene therapy for ischemic heart disease. |
| Q35218719 | Gene therapy for the treatment of heart failure--calcium signaling |
| Q36953151 | Gene therapy for the treatment of heart failure: promise postponed |
| Q36786243 | Gene therapy in the treatment of heart failure |
| Q40119187 | Gene-therapy delivery strategies in cardiology |
| Q35106501 | Genetic editing of dysfunctional myocardium |
| Q36179776 | MRI roadmap-guided transendocardial delivery of exon-skipping recombinant adeno-associated virus restores dystrophin expression in a canine model of Duchenne muscular dystrophy. |
| Q38081027 | Mechanistic, technical, and clinical perspectives in therapeutic stimulation of coronary collateral development by angiogenic growth factors |
| Q35360600 | Methods to improve cardiac gene therapy expression |
| Q30440788 | Myocardial gene transfer: routes and devices for regulation of transgene expression by modulation of cellular permeability |
| Q52763616 | Novel molecular targets for coronary angiogenesis and ischemic heart disease. |
| Q38113171 | Percutaneous approaches for efficient cardiac gene delivery. |
| Q37993680 | Percutaneous methods of vector delivery in preclinical models |
| Q45869682 | Percutaneous transcoronary venous access for cellular cardiomyoplasty |
| Q35621815 | Percutaneous transendocardial delivery of self-complementary adeno-associated virus 6 achieves global cardiac gene transfer in canines. |
| Q36497159 | Potential of gene therapy as a treatment for heart failure |
| Q34757960 | Rescuing the failing heart by targeted gene transfer |
| Q45885035 | Retroinfusion of NFkappaB decoy oligonucleotide extends cardioprotection achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs |
| Q59261110 | Selective Pressure-Regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia |
| Q37703070 | Site-specific gene therapy for cardiovascular disease. |
| Q34082093 | Surgical methods for cardiac gene transfer |
| Q37878086 | Targeted gene therapy for the treatment of heart failure |
| Q35990749 | Targeted high-efficiency, homogeneous myocardial gene transfer |
| Q36458906 | The Use of Gene Therapy for Ablation of Atrial Fibrillation |
| Q34317814 | The future of human gene therapy |
| Q53064896 | The relative anatomy of the coronary arterial and venous systems: implications for coronary interventions. |
| Q33705144 | The road ahead: working towards effective clinical translation of myocardial gene therapies |
| Q38128924 | Therapeutic potential of genes in cardiac repair |
| Q45856463 | Transthoracic direct current shock facilitates intramyocardial transfection of naked plasmid DNA infused via coronary vessels in canines. |
| Q44886456 | Vascular transfer of adenovirus is augmented by nitric oxide in the rat heart |
| Q34836871 | Virus-based gene delivery systems |
Search more.